首页|基于态靶辨证的补肾活血方联合泼尼松治疗重症免疫球蛋白A肾病临床观察

基于态靶辨证的补肾活血方联合泼尼松治疗重症免疫球蛋白A肾病临床观察

扫码查看
目的 探讨基于态靶辨证理论的补肾活血方联合泼尼松治疗重症免疫球蛋白A(IgA)肾病的临床疗效。方法 选取滦州市人民医院 2020 年 1 月至 2022 年 12 月收治的重症IgA肾病患者 98 例,按随机数字表法分为对照组和观察组,各 49 例。在常规治疗的基础上,两组患者均予醋酸泼尼松片口服,观察组患者基于态靶辨证理论加用补肾活血方,两组均以 30d为 1 个疗程,连续治疗 3 个疗程。结果 观察组总有效率为 91。84%,显著高于对照组的 73。47%(P<0。05)。观察组患者治疗后的中医证候(包括全身浮肿、小便不利、疲乏无力、舌淡苔白)积分均显著低于对照组,24 h尿蛋白定量、血尿素氮、血清肌酐水平均显著低于对照组,血清白蛋白水平显著高于对照组,血清水通道蛋白 3、过氧化物酶增殖物激活受体α、肾损伤因子-1 水平均显著低于对照组(P<0。05)。观察组与对照组不良反应发生率相当(14。29%比 10。20%,P>0。05)。结论 基于态靶辨证理论的补肾活血方联合泼尼松治疗重症IgA肾病,可改善患者的主要中医证候和肾功能指标,降低机体炎性因子水平。
Clinical Observation of Bushen Huoxue Formula Combined with Prednisone in the Treatment of Severe Immunoglobulin A Nephropathy Based on the Theory of State-Target Syndrome Differentiation
Objective To investigate the clinical efficacy of Bushen Huoxue Formula combined with prednisone in the treatment of severe immunoglobulin A(IgA)nephropathy based on the theory of state-target syndrome differentiation.Methods A total of 98 patients with severe IgA nephropathy admitted to the People's Hospital of Luanzhou from January 2020 to December 2022 were selected and divided into the control group and the observation group by the random number table method,with 49 cases in each group.The patients in the two groups were given conventional basic treatment and Prednisone Acetate Tablets orally,on this basis,the patients in the observation group were given Bushen Huoxue Formula based on the theory of state-target syndrome differentiation.Both groups were treated continuously for three courses with 30 d as a course.Results The total effective rate in the observation group was 91.84%,which was significantly higher than 73.47%in the control group(P<0.05).After treatment,the scores of traditional Chinese medicine(TCM)syndromes(including systemic swelling,poor urination,fatigue,weakness,pale tongue with whitish coating)in the observation group were significantly lower than those in the control group;the 24-hour urine protein(24 hUP),blood urea nitrogen(BUN)and serum creatinine(SCr)levels were significantly lower than those in the control group;the serum albumin(Alb)level was significantly higher than that in the control group;and the serum aquaporin 3(AQP3),peroxisome proliferator-activated receptor-α(PPAR-α),kidney injury molecule-1(KIM-1)levels were significantly lower than those in the control group(P<0.05).The incidence of adverse reactions in the observation group was similar to that in the control group(14.29%vs.10.20%,P>0.05).Conclusion Bushen Huoxue Formula combined with prednisone in the treatment of severe IgA nephropathy based on the theory of state-target syndrome differentiation can improve the main TCM syndromes and renal function indexes of patients,and reduce the level of inflammatory factors.

immunoglobulin A nephropathyglucocorticoidBushen Huoxue Formulastate-target syndrome differentiationclinical efficacytraditional Chinese medicine syndrome

王建立、薛翠英、袁秀梅、张红英、曾庆华、宋慧芳

展开 >

河北省滦州市人民医院,河北 唐山 063700

北京体育大学医院,北京 100085

免疫球蛋白A肾病 糖皮质激素 补肾活血方 态靶辨证 临床疗效 中医证候

河北省中医药管理局科研计划项目

2023420

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(4)
  • 18